Back to top

RBC Capital Remains a Buy on Chemours Company (CC)

RBC Capital analyst Arun Viswanathan maintained a Buy rating on Chemours Company on June 30 and set a price target of $26.00. The company’s shares ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

The Chemours Company (CC)